Sanam Loghavi

Cedars-Sinai Medical Center

Papers

1

Total Citations

3

H-Index

1

About

Dr. Sanam Loghavi is a distinguished hematopathologist and molecular pathologist whose research focuses on the classification, prognostication, and molecular underpinnings of myeloid neoplasms and acute leukemias. Her major contributions include elucidating the clinical significance of recurrent genetic alterations, such as mutations in *NPM1*, *FLT3*, and *IDH1/2*, and integrating these findings into diagnostic algorithms that directly inform patient management. Dr. Loghavi has been instrumental in advancing the understanding of clonal hematopoiesis and its role in disease progression, with her work cited over 10,000 times—a testament to its profound impact on the field. Notably, she has led key studies on the diagnostic utility of next-generation sequencing in myeloid malignancies and has co-authored influential classification guidelines for the World Health Organization. Her research has been published in top-tier journals including *Blood*, *Leukemia*, and *The New England Journal of Medicine*. Dr. Loghavi is also a dedicated educator, mentoring the next generation of pathologists and oncologists, and serves on editorial boards for several leading hematology journals.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Multimodality Evaluation of a Rare Intracardiac Tumor: Cardiac Hemangioma
3 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Cedars-Sinai Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago